BCRX R&D Expense Growth
Biocryst Pharmaceuticals Inc · R&D Expense Growth
BCRX R&D Expense Growth
Latest reported-4.87%period ending
BCRX FY R&D Growth (YoY) (0.00% → -4.87%)
Latest values, visible window
High-resolution chart · PNG
BCRX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -4.8741% | |
| -19.3604% | |
| -14.5012% | |
| 21.3062% | |
| 69.8123% | |
| 14.8466% | |
| 26.1285% | |
| 26.7704% | |
| 9.7594% | |
| -16.1494% | |
| 40.4703% | |
| 21.2169% | |
| -16.9711% | |
| -9.5504% | |
| -31.0101% | |
| 14.0674% | |
| -1.3974% | |
| -22.0361% | |
| 99.7563% | |
| 99.1482% | |
| 25.3034% | |
| 63.7573% | |
| -25.5372% | |
| 18.1989% | |
| 36.5024% | |
| 24.55% | |
| -17.2043% | |
| -12.2642% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |